BioCentury | Apr 4, 2013
Cover Story

Closer to class IIa HDAC inhibitors

...Immaculate's Dermatology Institute research hospital and treatment center and cofounder and CEO of oncology company Exiris...
...AB (SSE:ACTI), Lund, Sweden Celgene Corp. (NASDAQ:CELG), Summit, N.J. Dana-Farber Cancer Institute , Boston, Mass. Exiris...
Items per page:
1 - 1 of 1
BioCentury | Apr 4, 2013
Cover Story

Closer to class IIa HDAC inhibitors

...Immaculate's Dermatology Institute research hospital and treatment center and cofounder and CEO of oncology company Exiris...
...AB (SSE:ACTI), Lund, Sweden Celgene Corp. (NASDAQ:CELG), Summit, N.J. Dana-Farber Cancer Institute , Boston, Mass. Exiris...
Items per page:
1 - 1 of 1